Advertisement
Canada Markets closed
  • S&P/TSX

    23,027.15
    +245.72 (+1.08%)
     
  • S&P 500

    5,471.05
    +62.63 (+1.16%)
     
  • DOW

    40,829.59
    +484.18 (+1.20%)
     
  • CAD/USD

    0.7377
    +0.0008 (+0.1092%)
     
  • CRUDE OIL

    68.80
    +1.13 (+1.67%)
     
  • BTC-CAD

    77,752.19
    +3,932.60 (+5.33%)
     
  • CMC Crypto 200

    1,308.28
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,535.50
    +10.90 (+0.43%)
     
  • RUSSELL 2000

    2,097.78
    +6.37 (+0.30%)
     
  • 10-Yr Bond

    3.6970
    -0.0130 (-0.35%)
     
  • NASDAQ futures

    18,722.75
    +264.50 (+1.43%)
     
  • VOLATILITY

    19.45
    -2.93 (-13.09%)
     
  • FTSE

    8,270.84
    +89.37 (+1.09%)
     
  • NIKKEI 225

    36,215.75
    -175.72 (-0.48%)
     
  • CAD/EUR

    0.6681
    +0.0037 (+0.56%)
     

2 Ridiculously Cheap Growth Stocks to Buy Hand Over Fist in 2024

young people stare at smartphones
Source: Getty Images

Written by Christopher Liew, CFA at The Motley Fool Canada

Growth investing is one of the profitable stock-buying strategies. Capital gains or price appreciation is the primary focus, and growth stocks with visible strong upside potential are the investment choices. The TSX has several multi-bagger candidates, but there are two price-friendly if not ridiculously cheap options right now.

Payfare (TSX:PAY) and Healwell AI (TSX:AIDX) could soar higher than their current share prices in their respective sectors. The former caters to a fast-growing next-generation workforce, while the latter aims to deliver accurate diagnoses and treatment plans in the healthcare sector.

Financial technology

Payfare empowers next-generation workers in the gig economy. The $357.7 million financial technology company’s platform provides gig workers mobile banking and instant payment solutions, including loyalty rewards.

Further, the fintech partners with leading gig platforms like DoorDash, Lyft, and Uber to optimize worker payouts. The current share price is $7.35 (+18.4% year-to-date), while market analysts’ 12-month average price target is $11.33 (+54.2%).

The business is thriving, as evidenced by Payfare’s latest quarterly results. In the three months ending  June 30, 2024, revenue increased 20.4% year-over-year to a record $56 million. Net income climbed 131.6% to $4.9 million versus Q2 2024. For the first half of the year, profits ballooned 194% to $10 million from a year ago.

According to management, Payfare generates approximately 70% to 80% of its revenue from network interchange fees collected from payment networks. The rest, or 20% to 30%, are from user banking fees such as ATM withdrawals, money transfers, and foreign exchange.

Payfare also incurs little or no marketing costs since gig platforms initiate invitations to gig workers or market Payfare’s products and services. From Q1 2021, active users have grown exponentially from 146,842 to 1,468,770 in Q2 2024 (900.24%).

The fintech funds its growth objectives using internally generated free cash flow (FCF). At the quarter’s end, the $9.6 million FCF is 4,700% higher than the same period in 2023. Notably, Payfare has zero debt. Management added that the sixth-consecutive earnings-positive quarter in Q2 2024 indicates consistent profitability.

In early March this year, Uber announced the launch of the Uber Pro Card in Canada in partnership with Payfare and Mastercard. On July 25, 2024, Payfare signed a long-term contract extension with Lyft to ensure continued collaboration and future product enhancements.

Healthcare technology

Healwell AI continues to deliver astronomical returns in 2024. At only $1.93 per share, current investors enjoy a 157.3% year-to-date gain. Had you invested $5,000 on year-end 2023, your money would be $12,866.67 today. Market analysts recommend a strong buy rating and forecast a 91.2% upside in one year.

The $322.6 million healthcare technology company believes that artificial intelligence (AI) can help make healthcare more predictive and proactive. Healwell uses AI to analyze big data and develop improved preventive care recommendations for patients.

Because of organic growth, strategic mergers, and a robust acquisition pipeline, Dr. Alexander Dobranowski, CEO of Healwell, expects the current $20 million plus revenue to soon exceed $40 million annually.

Strong buys

Payfare and Healwell AI are buying opportunities for their low prices vis-à-vis their visible and enormous high-growth potential.

The post 2 Ridiculously Cheap Growth Stocks to Buy Hand Over Fist in 2024 appeared first on The Motley Fool Canada.

Should you invest $1,000 in Healwell Ai right now?

Before you buy stock in Healwell Ai, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Healwell Ai wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $16,864.27!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 27 percentage points since 2013*.

See the 10 stocks * Returns as of 7/31/24

More reading

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Payfare. The Motley Fool recommends DoorDash, Mastercard, and Uber Technologies. The Motley Fool has a disclosure policy.

2024